agar gak bosan,  tengok lagi perkembangan terkini di Afsel :

Kutip

US project planning to sterilise HIV+ women in SA

11.04.2011

A controversial US project that pays drug users and alcoholics to undergo sterilisation or long-term contraception, is setting its sights on women living with HIV in South Africa.

Founder of Project Prevention Barbara Harris has confirmed that they were making plans to offer similar services to women living with HIV in South Africa as well as drug users.

"We have had huge interest in South Africa from organisations and concerned citizens," said Harris, adding that they would be joining forces with local non-governmental organisations.

While she declined to identify them, she said "we have many wanting to work with us".

"How can anyone object to anything that can prevent innocent children suffering needlessly?" asked Harris.

However, Professor Eddie Mhlanga, Chief Director for Maternal, Child and Women's Health in the health department said they would approach the Human Rights Commission if the project started operating in South Africa.

He also warned that doctors found co-operating with the organisation in any medical interventions would be reported to the Health Professions Council of South Africa.

"We do not support it and we find it very worrisome," said Mhlanga.

Project Prevention is already operating in parts of Kenya, where it is paying women living with HIV U$40 to accept long-term contraception. A doctor is paid U$7 per patient.

In Kenya, Project Prevention is working in Nyanza province where they place woman in groups of between 10 and 15 and give them a pooled amount of money to begin income-generating activities in return for accepting intrauterine devices (IUDs) as long-term contraception. Each woman then receives around R280 in return.

A Project Prevention statement released in December last year said there was a need "...to work on getting women living with HIV/AIDS on long term birth control to prevent future pregnancies that may result in suffering children."

It also stated that long term birth control was the "only way those numbers will become fewer."

Project Prevention co-ordinator in Kenya Willice Okoth also confirmed they were planning to work in South Africa and claimed they were teaming up with "individuals" from a doctor and medical insurance network.

Harris started the organisation in 1997 and has famously been quoted as saying in reference to drug addicts: "We don't allow dogs to breed. We spay them. We neuter them. We try to keep them from having unwanted puppies, and yet then women are literally having litters of children."

Harris' organisation started operating in the United Kingdom late last year, but her sterilisation attempts were met with stiff opposition from the British Medical Association. Project Prevention has since opted to offer payment for long-term sterilisation instead.

Women in the US are paid U$300 (R2 100).

Various medical interventions, some available to state patients in South Africa,  enable women living with HIV to have perfectly healthy babies.

"We cannot accept a situation where organisations come and exploit poor and defenseless people and we find it unethical that they are asking people to for a certain fee give up their reproductive rights," said Mhlanga.

"Why are they specifically targeting people who are drug users or living with HIV? They are no less people," he said.

Professor Di Cooper, head of the Women's Health Research Unit at the University of Cape Town said the project went against the core of women's sexual and reproductive rights recognised in the South African Constitution which gives women a free, non-coercive choice in terms of reproduction.

"The offering of money could be seen as bribery and is effectively coercive."

She said the emphasis on "preventing innocent children suffering" and the "very derogatory" statement by Harris likening women to "breeding dogs" did not bode well.

"This has no place within the human and reproductive rights culture in South Africa, particularly given our history of human and reproductive rights abuse under apartheid," said Cooper.

Dr Eric Goemaere of Medecins Sans Frontieres South Africa said the analogy with dogs was "very unfortunate" as it tends to trivialise the issue while access to family planning is a real issue in rural SA and many countries in Africa.
"Key issues are of course the women's choice, steering clear of any form of irreversible sterilisation," he said.

Bla bla bla......lagi-lagi propaganda yang disodorkan.

ZZZZZZzzzzzz......

Kutip
 
National HIV Vaccine Awareness Day

May 18, 2011

Statement of Anthony S. Fauci, M.D.
Director, National Institute of Allergy and Infectious Diseases
National Institutes of Health

Thirty years since the first report of the disease we now know as AIDS, scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, continue advancing toward our goal of a vaccine to prevent HIV infection. I am optimistic that we will succeed.

We have scientific evidence that a safe and effective HIV vaccine is possible. In 2009, a clinical trial in Thailand involving 16,000 people demonstrated for the first time that a vaccine could safely prevent HIV infection in a modest proportion of study participants. Many of the best minds in HIV vaccine science are examining blood samples and data from the Thai trial to learn how the vaccine candidate prevented HIV infections and to consider how it could be modified to be more effective.

To speed the pace at which promising HIV vaccine candidates become viable for evaluation in large clinical trials, NIAID is exploring the use of innovative or adaptive clinical trial designs that let scientists quickly modify ongoing trials in response to data acquired during the study. Such flexibility in trial design will allow the research community to maximize efficiencies in studying vaccine candidates. 

Clinical trials of HIV vaccines depend on the participation of thousands of volunteers as well as community educators, health care workers and scientists. I am extremely grateful to the many people who devote their time and energy to these essential clinical studies.

Every HIV vaccine candidate is created in the laboratory. Some NIAID-supported laboratory scientists are charting a new course by designing HIV vaccine candidates based on knowledge of the protein structure of the surface spikes that HIV uses to attach to and infect human cells. These spikes have sites that are vulnerable to powerful antibodies, which block laboratory infection of human cells by more than 90 percent of tested HIV strains from around the globe. Now the scientists are mapping a strategy to create a vaccine that can stimulate a healthy person to make such broadly neutralizing antibodies.

To guide HIV vaccine design, other NIAID-supported scientists are building on evidence that in most individuals, only a small number of HIV particles—often just one—are responsible for establishing a sexually transmitted HIV infection. These researchers are identifying the unique qualities of these infection-causing forms of the virus to help other scientists design vaccines that target the specific HIV variants that penetrate the body's defenses.

No matter how effective a preventive HIV vaccine is, however, we will need to evaluate and administer it in combination with other biomedical and behavioral HIV prevention tools. No single HIV prevention strategy will control and ultimately end the HIV/AIDS pandemic. That is why it is important for NIAID to continue supporting promising research on vaginal and rectal microbicides, pre-exposure prophylaxis (PrEP) and expanded HIV testing with linkage to care. That is also why public health workers will continue to advocate and implement scientifically proven HIV prevention strategies such as condom use, medically supervised adult male circumcision, harm-reduction strategies for injection drug users and the prevention of mother-to-child transmission of HIV.

On this extraordinarily challenging journey to develop a preventive HIV vaccine, taking a moment today to reflect on our progress gives us all renewed hope that our goal is achievable.

Media inquiries can be directed to the NIAID Office of Communications at 301-402-1663, [email protected].

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at [pranala luar disembunyikan, sila masuk atau daftar.]

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit [pranala luar disembunyikan, sila masuk atau daftar.]

Kutip dari: semut-ireng pada Mei 14, 2011, 08:48:27 AMCIAP CIAP CIAP......

*Ignored, bosan dengan propaganda usang*

Kutip dari: Pi-One pada Mei 14, 2011, 10:43:40 AM
*Ignored, bosan dengan propaganda usang*

jadi,  statemen resmi pemerintah,  dikeluarkan oleh institusi bergengsi NIH itu propaganda usang ??

kalo yang saya sampaikan di bawah ini jangan2 dipandang propaganda usang juga : ?

11 May – NEW YORK – OMSJ congratulates to Nancy T. Banks MD, MBA, whose book,"  AIDS, Opium, Diamonds and Empire," has won a gold medal for "the most progressive health book," by the Independent Publisher Book Awards.  The award ceremony will be in NY on May 23rd.

[pranala luar disembunyikan, sila masuk atau daftar.]

Dalam bukunya,  Nancy [pranala luar disembunyikan, sila masuk atau daftar.] mengungkap asymmetric war.

Kutip
  It is a mistake to think that wars only concern armies involved in active engagement. Nothing is farther from the truth. The real forces of evil wage a financial war. The dark princes of debt finance have gained leverage over every important social, economic, and political institution-including the health care delivery system.

In AIDS, Opium, Diamonds, and Empire, author Nancy Turner Banks draws the connections between free market strategies, the destruction of national sovereignty by the process of globalization, and AIDS as one of the health consequences of a neo-Darwinian philosophy. Through meticulous research, Banks found a medicalpharmaceutical- industrial complex that was taken over one hundred years ago by the titans of financial capitalism. Their aim was to create profit, not to conquer disease. This book of social history points to a cauldron of historical events that contributed to the HIV/AIDS crisis.

AIDS, Opium, Diamonds, and Empire tells the dramatic story of a financial ideology that is damaging to everything that it means to be human. It is the story of profits over people. In the end, it is the story of hope and how we can regain our sanity and our health in a world gone mad.

Kutip dari: semut-ireng pada Mei 15, 2011, 06:33:00 AMonly for idiot

Kutip dari: semut-ireng pada Mei 15, 2011, 08:57:18 AMfor idiot only

*ignored*

 and AIDS as one of the health consequences of a neo-Darwinian philosophy.

( Nancy T.Banks )

Kutip dari: semut-ireng pada Mei 16, 2011, 01:04:31 PM
aho...ichiban aho...

Dumber and dumber...ignored*

masih lanjut to???

boleh nanya gk boss ?

Kutip dari: No pada Mei 23, 2011, 10:54:47 AM
masih lanjut to???

he, kangen juga ya dengan thread panasnya forsa ??

Kutip dari: smadav pada Mei 26, 2011, 08:13:06 AM
boleh nanya gk boss ?

monggo mas,  berkaitan dengan topik tentunya,  nanti kita bahas sama2.

Kutip dari: No pada Mei 23, 2011, 10:54:47 AM
masih lanjut to???

Yah, si asbuner masih gemar nyebar racun propaganda. Belum puas dia kalau epidemi HIV/AIDS belum mewabah di Indonesia lebih parah dari sekarang...

Lupus Causes HIV Positive Results

RTB: HIV tests come up positive for everything. Here researchers find that 'specific' HIV test proteins are...yes, non-specific. Again. And again. And again. But, they note, anyone with an 'autoimmune disease' should always be tested for "HIV!"

What about the 'false' results? They declare using a Western Blot should sort it out. Never mind that Western Blots contain precisely the same proteins as ELISA tests. Never mind that they have no standards for interpretation from lab to lab, country to country; or that some countries, like the UK, won't use them because they consider them so awful!

But because the tests are so awful, they 'suggest' using PCR. Which work just as well. Ehm...badly. You can read about the wonders of PCR Here – these tests also have no standard, give no reproducible results, and come up positive and negative in the same sample from lab to lab, hour to hour, minute to minute. It's a real 'wheel of fortune' with "HIV Testing."

False positive results for antibody to HIV in two men with systemic lupus erythematosus. [PDF] [Link]

M H Esteva, A M Blasini, D Ogly and M A Rodri?guez?Ann Rheum Dis 1992;51;10711073 doi:10.1136/ard.51.9.1071

Abstract: False positive results were obtained for HIV tests in two men with active systemic lupus erythematosus (SLE) who were suspected of being infected with HIV because of fever, weight loss, lymphadenopathy, and inflammatory myopathy. Enzyme linked immuno sorbent assays (ELISAs) for HIV were twice positive when tested three times over a period of six months.Western blot analysis showed reactivity against the gp4l band in patient 1. False positive results for HIV tests can occur in patients with SLE, potentially leading to an erroneous diagnosis of HIV infection.

Interestingly Golding et al'2 showed cross reacting antibodies recognising the HIV gp41 protein and the 13 domain of human major histocompatibility complex class II molecules in serum samples from patients with AIDS. Okudaira et all' have reported the presence of antibodies to HLADR molecules in serum from patients with SLE. It is possible that serum samples from patient 1 had this pattern of cross reacting antibodies in the absence of HIV infection. Antibodies to the p24 gag protein of HIV1 have also been reported in patients with SLE.'4 Whether these antibodies arise by molecular mimicry to homologous host proteins or reflect viral infection remains to be established.

The diagnosis of HIV infection should always be considered in patients presenting with clinical symptoms suggestive of asystemic autoimmune disease. The use of rigorous confirmatory testing by western blot analysis or immuno fluorescence assay is therefore mandatory. More sensitive assays such as gene amplification by the polymerase chain reaction may be necessary to confirm the presence of HIV infection in patients with unclear serological reactions.


[pranala luar disembunyikan, sila masuk atau daftar.]

namanya analisis klinik pasti punya batasan akurasi, presisi dan selektivitas.
itulah knp analisis tidak dilakukan hanya dengan satu metode.
see?